Reminder to longs (including myself) and intro to
Post# of 85484
EuroMed aims to be a leading low-cost, high-quality, medical-grade cannabis producer in Israel with a focus on both the domestic Israeli market and the emerging European cannabis market.
EuroMed, through its wholly owned Israeli subsidiary, Eurocann Agritech Ltd., owns a 74-per-cent equity stake in a 269,098-square-foot (25-dunam) cannabis designated cultivation property located 45 minutes outside of Jerusalem, Israel. EuroMed inteads to build a 22,000-square-foot greenhouse facility on the property to cultivate medical-grade cannabis for the purposes of servicing the domestic medical cannabis market and exports into Europe. EuroMed will be working with leading greenhouse engineering and construction firm Eisenberg Agri company (Israel) Ltd. (EACi) to design and build a state-of-the-art modular greenhouse facility with expected completion by March, 2020.
30+ medications. "Euromed puts us 20 years ahead of the competition" -Dr David Dalton